Meeting Preview | The ‘Global Brain-Computer Interface Industry Development White Paper’ will be released at the Frost & Sullivan Life Science New Investment Summit Forum Medical Devices Session

The 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and 5th New Investment Conference, hosted by global leading growth consulting firm Frost & Sullivan, also known as Frost & Sullivan, will be held from August 4-5, 2026, in Shanghai. During the conference, a new investment forum on life sciences will be launched. The forum will feature three parallel sessions focusing on biomedicine, medical devices, and health technology, presenting cutting-edge topics and latest insights. With the core concept “Driving Change through Innovation, Advancing with Resilience”, the forum invites industry leaders, biomedicine and medical device companies, health technology firms, investment institutions, and professional services organizations to discuss emerging trends in life sciences, innovative technologies, and global development paths, aiming to promote industrial upgrading and global collaboration.The “Global Brain-Computer Interface Industry White Paper” will be released during the medical device session of the Life Sciences New Investment Forum on August 5.

Host City: Shanghai, China

Date: August 4-5, 2026

Conference Scale: 5,000+

Format: Offline + Online Live Streaming

Organizer: Frost & Sullivan

Scan the QR code to register immediately

Currently, brain-computer interfaces are moving from advanced research in laboratories to a critical stage of clinical translation and industrial development. The 2026 Government Work Report includes brain-computer interfaces in national future industry plans for the first time, further clarifying their strategic importance.This means that brain-computer interfaces are no longer just a single technical direction formed by the intersection of neuroscience and engineering technology, but also represent a future industry that carries multiple values such as life and health (neurological disease intervention and human function restoration), technological autonomy (electrodes, chips, algorithms, and systems being self-controlled), and industrial upgrading (human-machine interaction and bio-intelligence integration).

At this important moment of accelerated evolution in this industry, Frost & Sullivan will release the “2026 Global Brain-Computer Interface Industry White Paper”. Based on a global industry perspective, the white paper systematically outlines the technological evolution, clinical applications, regulatory policies, industrial ecosystem, and commercialization process of brain-computer interfaces, aiming to provide a research report with international benchmarking value and industrial reference significance for scientific research institutions, medical institutions, industrial enterprises, investment institutions, and policymakers.

The white paper establishes a research framework that takes into account global perspectives, technical depth, and industrial chain coverage. It focuses on different technical approaches such as non-invasive, semi-invasive, interventional, and invasive methods, and deeply analyzes the application progress of brain-computer interfaces in neurological regulation, motor function restoration, visual and linguistic restoration, as well as in daily life, industry, and military scenarios. By comparing regulatory paths, clinical access, medical insurance payment, research ecosystem, investment and financing trends, and representative enterprises between China and the US, a four-dimensional analysis framework of “technology—clinical—regulation—commercialization” is formed to help industry participants better understand the current stage of the industry and grasp key trends and long-term development opportunities.

Starting from basic definitions, operating principles, technical classifications, and application landscapes, the development of the brain-computer interface industry is presented comprehensively. As an important technical platform connecting biological intelligence and machine intelligence, brain-computer interfaces are accelerating the construction of two-way information channels from “brain to machine” and “machine to brain”, and are moving from one-way reading or stimulation to two-way closed loops, multi-modal integration, and intelligent adaptation. With the expansion of applications in medicine, daily life, industry, and military, brain-computer interfaces are expected to become an important force in promoting the upgrade of human-machine interaction paradigms, fostering life and health innovation, and cultivating future industries.

Focusing on the core chain consisting of “neural signal acquisition—signal processing and decoding—neural encoding and stimulation feedback”, the technical system of brain-computer interfaces from signal reading, intent interpretation to information writing back, as well as key engineering foundations such as electrodes, chips, wireless transmission, power supply, and packaging are comprehensively reviewed. With continuous breakthroughs in flexible electrodes, deep learning, self-supervised pre-training, large neural signal models, and closed-loop adaptive control technologies, the signal quality, interaction efficiency, and long-term stability of brain-computer interfaces are improving continuously. In the future, collaborative innovations in low noise, low power consumption, high channels, real-time response, and biocompatibility will further strengthen the foundation for industrialization and large-scale applications.

Focusing on the clinical value of brain-computer interfaces in the treatment of neurological diseases and human function restoration, the two main application areas of “closed-loop neural regulation” and “neural function restoration” are presented comprehensively. Adaptive DBS,RNSand closed-loop SCS technologies are promoting more precise and personalized closed-loop interventions for Parkinson’s disease, epilepsy, and chronic pain treatment; motion intent decoding, epidural electrical stimulation, and brain-computer interfaces are bringing new possibilities for patients with spinal cord injuries and those recovering motor functions after stroke. At the same time, progress continues to be made in visual, linguistic, and auditory restoration, as well as in the intervention of mental and cognitive diseases such as depression andADHD, driving brain-computer interfaces to expand from symptom management to functional restoration, ability reconstruction, and lifelong health management.

Expanding the application scope of brain-computer interfaces from the medical field to daily life, industry, and military scenarios, demonstrating their potential in broader human-machine collaboration systems. In the daily life sector, applications such as education, gaming, sleep, and smart homes are promoting non-invasive brain-computer interfaces to enter the mass market. Among them,sleep technologyhas gradually formed a closed-loop model of “monitoring—evaluation—intervention”; in the industry sector, brain-computer interfaces are expanding from personnel status monitoring and risk early warning to brain-controlled devices and high-risk operation substitution; in the military sector, related technologies are expected to enhance state perception, decision support, equipment control, and cognitive efficiency. With the continuous improvement of signal accuracy, anti-interference capabilities, and system reliability, as well as the gradual improvement of privacy and ethics governance systems, the scale application space in various scenarios will be further opened up.

Comparing the regulatory systems and industrial policies of brain-computer interfaces in China and the US, it shows a new stage in the global brain-computer interface industry from advanced research exploration to standardized clinical translation. The US has established a clear access mechanism for innovative products through FDA risk classification, IDE, breakthrough device program, 510(k), De Novo, PMA and other review pathways. China, with NMPA andCMDEas the core, continuously improves risk classification, technical review, industry standards, and green channel for innovative medical devices, and strengthens industrial support through national strategies, ethical norms, and medical service price items. As regulatory, clinical, and payment systems become more integrated, the institutional foundation for the commercialization of brain-computer interfaces is becoming increasingly mature.

Comprehensively analyzing the development environment and future trends of the global brain-computer interface industry from aspects such as scientific research innovation, clinical translation, capital investment, industrial infrastructure, and regional clustering. China and the US have formed the first tier of global brain-computer interface scientific research innovation: the US continues to lead in frontier breakthroughs relying on top universities, mature clinical systems, and long-term capital support, while China accelerates the connection of achievement conversion links through research institutes,brain-computer interface wards, industrial platforms, and regional cluster construction. Looking to the future, brain-computer interfaces will accelerate integration with artificial intelligence, spatial intelligence, and embodied intelligence, forming a two-way closed loop of “brain—AI—embodied device—physical world”, enabling human-machine interaction to move from intent recognition to intent understanding, action planning, and real-world execution.

Through global representative enterprise cases, the innovative pattern of multiple technical approaches, multiple application directions, and full-value chain collaboration in the brain-computer interface industry is presented comprehensively. International companies such as Neuralink and Synchron explore full-invasive and interventional technical approaches, while Chinese companies have diversified layouts in flexible electrodes, high-throughput implant systems, closed-loop neural regulation, brain-computer interfaces, visual restoration, sleep and cognitive health, rehabilitation devices, and specialized chips. As technology, clinical, regulatory, and manufacturing capabilities continue to mature, industry competition is evolving from single-technique breakthroughs to comprehensive competition in full-stack research and development, clinical value, registration transformation, scale delivery, and scenario operation. The brain-computer interface industry is also moving from technical verification to productization and scale development in a new stage.

Life Sciences New Investment Forum

Event inquiries | Sponsorship cooperation | Registration inquiries

📞 Conference inquiry hotline:

021-3209-6800 ext. 8672

📧 Conference inquiry email:

gil@frostchina.com